Arcadia Investment Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-537
Closed -$132K 357
2022
Q3
$132K Hold
537
0.03% 138
2022
Q2
$133K Hold
537
0.03% 145
2022
Q1
$178K Hold
537
0.03% 139
2021
Q4
$193K Hold
537
0.03% 146
2021
Q3
$175K Hold
537
0.03% 143
2021
Q2
$168K Hold
537
0.03% 145
2021
Q1
$171K Hold
537
0.03% 139
2020
Q4
$174K Hold
537
0.04% 121
2020
Q3
$149K Buy
+537
New +$155K 0.03% 130
2018
Q4
Sell
-537
Closed -$242K 335
2018
Q3
$242K Hold
537
0.06% 110
2018
Q2
$220K Hold
537
0.06% 114
2018
Q1
$156K Hold
537
0.04% 134
2017
Q4
$101K Hold
537
0.03% 164
2017
Q3
$91K Hold
537
0.03% 169
2017
Q2
$77K Buy
537
+200
+59% +$26.9K 0.02% 183
2017
Q1
$42K Buy
+337
New +$39.1K 0.01% 231
2016
Q3
Sell
-382
Closed -$42K 447
2016
Q2
$42K Buy
+382
New +$38K 0.01% 217

Other funds holding ABMD

Arcadia Investment Management's ABMD Position: Q4 2022 in Review

Arcadia Investment Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 537 shares — an estimated $132K sold.

Arcadia Investment Management first reported a position in ABMD in Q2 2016 and held it in 17 quarters. The position peaked at $242K in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Arcadia Investment Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Arcadia Investment Management sold 537 Abiomed Inc shares in Q4 2022, an estimated $132K.
  • Arcadia Investment Management first reported a position in Abiomed Inc in Q2 2016 and held it in 17 quarters.
  • Arcadia Investment Management's Abiomed Inc position peaked at $242K in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Arcadia Investment Management's 13F filing for Q4 2022, filed 8 Feb 2023.